Our company is driven by a passion to help patients. We partner with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring to help patients live longer, healthier and more productive lives.
Lowell Edwards dreams of creating an artificial heart
First successful mitral valve replacement using the Starr-Edwards Silastic ball valve
Edwards Laboratories established in Orange County, CA
Development of the Fogarty embolectomy catheter spawns Edwards’ Vascular business
Development of the Swan-Ganz pulmonary artery catheter spawns Edwards’ Critical Care business
Carpentier-Edwards porcine bioprostheses launch
Carpentier-Edwards PERIMOUNT pericardial bioprostheses introduced
Introduction of the VAMP system
Carpentier-Edwards Physio annuloplasty ring introduced
Introduction of the Vigilance monitor
Introduction of the TruWave Transducer
Edwards Lifesciences spins off from Baxter and trades on the NYSE: EW
Grand opening of Haina, Dominican Republic manufacturing facility
Edwards acquires Percutaneous Valve Technologies
Introduction of FloTrac minimally-invasive hemodynamic monitoring
Edwards SAPIEN transcatheter heart valve introduced in Europe
Grand opening of Singapore heart valve manufacturing facility
Edwards SAPIEN XT transcatheter heart valve introduced in Europe
Grand opening of Draper, Utah manufacturing facility
EV1000 clinical platform and VolumeView set introduced in Europe
Edwards SAPIEN transcatheter heart valve introduced in the U.S.
ThruPort systems for MIVS introduced worldwide
EDWARDS INTUITY valve system introduced in Europe
Edwards SAPIEN XT transcatheter heart valve introduced in Japan
ClearSight noninvasive monitoring system introduced in Europe
Edwards SAPIEN 3 transcatheter heart valve introduced in Europe
EDWARDS INTUITY Elite valve system introduced in Europe
ClearSight noninvasive monitoring system introduced in the U.S.
Edwards SAPIEN XT transcatheter heart valve introduced in the U.S.
Edwards SAPIEN 3 transcatheter heart valve introduced in the U.S.
Edwards HemoSphere advanced monitoring platform introduced in Europe
Edwards Acumen Hypotension Probability Indicator (HPI) software introduced in Europe
Edwards HemoSphere advanced monitoring platform introduced in the U.S.
Caution: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
Please update to a current version of your preferred browser, this site will perform effectively on the following:
If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility